Navigation Links
Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort
Date:1/31/2011

Retired San Francisco real estate developer Douglas Rosenberg says he has a new job helping to find a cure for Alzheimer's disease. Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist is betting at least $3.5 million that Buck faculty Dale Bredesen, MD has the correct take on how to thwart the memory robbing disease that affects over 5 million Americans. The two have formed a unique partnership aimed at developing treatments based on the results of small molecule screenings that show promise in cell culture and animal models of the disease. Rosenberg's goal is to raise at least $10 million to get the new drug candidates into early clinical trials.

"We can't afford to wait, I can't afford to wait," said Rosenberg. "Big Pharma is not stepping up to the plate and the federal government, through the National Institutes of Health, is not providing money for this type of drug development either."

Rosenberg has seen the worst of Alzheimer's. His father, prominent San Francisco businessman and nationally-renowned philanthropist Claude Rosenberg, Jr. died from the neurodegenerative disease in 2008. His stepfather died from the condition that same year. His stepmother succumbed to complications of Alzheimer's in 2010.

A friend invited Rosenberg to hear Bredesen speak at the Stanford Marin Club in November 2007. Rosenberg said he got excited about Bredesen's research. "It was a fresh approach -- he was taking a look at the root causes of Alzheimer's way upstream from other work I was familiar with," said Rosenberg. "Ironically, I had never been to a Stanford function before, so I assumed it wasn't an accident that we met." The two men became friends.

Bredesen, an academic neurologist turned researcher, focuses on Alzheimer's as a disorder involving an imbalance in signaling between neurons that impacts brain plasticity, rather than the current dogma that Alzheimer's is a disease of toxicity stemming predo
'/>"/>

Contact: Kris Rebillot
krebillot@buckinstitute.org
415-209-2080
Buck Institute for Age Research
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Philanthropist Mark Jenney Donates to Cystic Fibrosis Foundation
2. Regence Invests in Kinetix Living Corp.
3. Amway One by One Campaign for Children Reaches 7 Million Kids
4. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. New Report: $1 Cigarette Tax Increase Would Raise $418.8 Million for Texas and Cut Youth Smoking
7. New Report: $1 Cigarette Tax Increase Would Raise $18.6 Million for Montana and Cut Youth Smoking
8. New Report: $1 Cigarette Tax Increase Would Raise $24.8 Million for Wyoming and Cut Youth Smoking
9. New Report: $1 Cigarette Tax Increase Would Raise $43.3 Million for Utah and Cut Youth Smoking
10. New Report: $1 Cigarette Tax Increase Would Raise $113.9 Million for Colorado and Cut Youth Smoking
11. New Report: $1 Cigarette Tax Increase Would Raise $65.3 Million for Iowa and Cut Youth Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MO (PRWEB) May 29, 2015 Based in ... autism awareness shirts for a couple of months ... Their latest release, which reads “I’m not misbehaving, I ... worn by the parent’s of an autistic child in order ... of autism. , Not only are they raising awareness through ...
(Date:5/29/2015)... M3 USA MDLinx.com, source of the ... specialties, now offers The Smartest Rheumatologist . The ... disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis and ... MDLinx, and Caroline Tredway, editorial head of The Smartest ... have on the physicians who participate. Says Tredway, “With ...
(Date:5/29/2015)... PALMER LAKE, CO (PRWEB) May 29, 2015 ... a brand new addiction, substance abuse, and co-occurring ... Opening celebration and ribbon cutting for the general ... patients June 2nd. , The Recovery Village at ... hospitalization, and intensive outpatient programming, utilizing traditional and ...
(Date:5/29/2015)... 29, 2015 On May 21, 2015, Elle ... When You Get Botox ?” reported on the four ... Elle partnered with Google to determine these results and then ... question in California, for example, is how to keep ... search query is what's the appropriate age to start receiving ...
(Date:5/29/2015)... 2015 Johnson & Johnson and ... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a ... his use of the antipsychotic medication. According to ... the third bellwether trial to involve male breast ... in Pennsylvania’s Philadelphia Court of Common Pleas, where ...
Breaking Medicine News(10 mins):Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3
... TOWN, W. Va., Oct. 3 In advance ... (Pink Sheets: RBRM) noted today that each month ... compared to the same month in 2006 for ... biggest problem is,having enough space for the increase ...
... Oct. 3 The National,Fibromyalgia Association today announced ... Bremer, III, will be its designated spokeswoman to,help ... chronic,pain illness that experts believe affects up to ... population. Mrs. Bremer was diagnosed with fibromyalgia ...
... John Legend and Wyclef Jean join Terrence Howard, Natalie, ... WEEKS) T-Shirt and ... latest Gap (PRODUCT) RED collections, SAN FRANCISCO, Oct. 3 ... (PRODUCT) RED, a for-benefit,brand designed to help eliminate AIDS in ...
... Predictive medicine company,PreMD Inc. (TSX: PMD; Amex: PME) ... 510(k) application to the US Food and Drug ... Wednesday, October 3, 2007, Dr. Brent Norton, president ... BioContact Quebec, a leading,annual biopharmaceutical conference. The conference ...
... New research from the Howard Florey Institute in Melbourne ... cause epilepsy in infants. , Infants are more susceptible ... rapid rate, making their brain cells excitable. Their neurons ... cells, which can disrupt normal brain activity and results ...
... Today the European Molecular Biology Laboratory (EMBL), the ... Norway, and Ume University, Sweden, officially launch their ... agreement will encourage scientific exchange and collaborations between ... scientific infrastructure, facilities and services for an initial ...
Cached Medicine News:Health News:ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007 2Health News:ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007 3Health News:Frances Winfield Bremer, Wife of Ambassador L. Paul Bremer, III, to Become Spokeswoman for the National Fibromyalgia Association 2Health News:Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED 2Health News:Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED 3Health News:Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED 4Health News:PreMD Inc. Provides Corporate Update 2Health News:PreMD Inc. Provides Corporate Update 3Health News:Research shows how genetic mutation causes epilepsy in infants 2Health News:EMBL reaches north 2
(Date:5/29/2015)... DUBLIN , May 29, 2015 ... has announced the addition of the "Surgical/Operating ... Global Forecast to 2020" report to their ... The global surgical microscopes market is poised to ... in 2014, at a CAGR of 12.3% from ...
(Date:5/29/2015)... -- Eli Lilly and Company (NYSE: LLY ) and ... have entered into a clinical trial collaboration to evaluate ... immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ® ... The planned study will assess the combination as a ... The Phase I study is expected to establish the ...
(Date:5/28/2015)... Ind. , May 28, 2015 Zimmer ... that it has finalized agreements with buyers to divest ... Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow ... agreements are in furtherance of Zimmer,s pending acquisition of ... Zimmer continues to work constructively with the Bureau ...
Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6
... announced today at MD&M West in Anaheim that it will ... on its success since its 2010 launch. As part of ... database product will become part of Qmed, the world,s only ... device OEMs. As part of the new alignment, the CDM ...
... Human Services (HHS) Secretary Kathleen Sebelius should continue encouraging ... despite opposition from the independent drugstore lobby, the ... "Medicaid can no longer afford to spend more ... should have the flexibility to use the tools other ...
Cached Medicine Technology:UBM Canon Announces Significant Investment and Development Plans for the Next Generation of Qmed.com 2UBM Canon Announces Significant Investment and Development Plans for the Next Generation of Qmed.com 3PCMA: Focus on Patients, Not Profits, in Medicaid Pharmacy 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: